A Feed-Forward Regulatory Loop Between HuR and the Long Noncoding RNA HOTAIR Promotes Head and Neck Squamous Cell Carcinoma Progression and Metastasis
Overview
Cell Biology
Pharmacology
Affiliations
Background/aims: The lncRNA Homeobox (HOX) transcript antisense RNA (HOTAIR) is overexpressed in numerous cancers. HuR is also overexpressed during tumourigenesis and is abnormally present within the cytoplasm, where it binds to AU-rich elements in the 3'UTRs of target mRNA and post-transcriptionally regulates the expression of its target genes. However, whether HOTAIR is regulated and the mechanisms by which it affects head and neck squamous cell carcinoma (HNSCC) are not well understood.
Methods: MTT, cell cycle arrest and apoptotic assays were used to examine the effects of HOTAIR and HuR on cell viability in SCC25 and FaDu cells. Wound healing and transwell invasion analysis were performed to detect the effects of HOTAIR and HuR on cell migration and invasion. The interaction between HuR and HOTAIR was confirmed via qRT-PCR, western blots, luciferase reporter and RIP assays. Finally, qRT-PCR analysis was used to detect the levels of HuR and HOTAIR in HNSCC tumours and adjacent normal tissues.
Results: Knockdown of HOTAIR and HuR decreased cell viability, cellular migration and invasion. Moreover, HuR interacted and stabilized HOTAIR stability and thus promoted HOTAIR expression. Notably, HOTAIR acted as a miRNA sponge for HuR. HuR also reinforced HOTAIR sponge activity through miRNA recruitment, thus enhancing HuR expression in turn. Finally, HuR and HOTAIR levels were positively correlated and significantly up-regulated in tumours samples.
Conclusion: We demonstrated the existence of a regulatory loop in which the expression of HOTAIR and HuR is reciprocally and temporally regulated during the metastasis and progression of HNSCC.
Li Y, Sun W, Li J, Du R, Xing W, Yuan X Bone Res. 2023; 11(1):53.
PMID: 37872163 PMC: 10593784. DOI: 10.1038/s41413-023-00289-2.
Li Y, Miao H, Wei W, Tian J, Chen J Acta Biochim Biophys Sin (Shanghai). 2023; 55(2):225-236.
PMID: 36647722 PMC: 10157633. DOI: 10.3724/abbs.2022197.
Yang G, Huang T, Wu Y, Wang J, Pan Z, Chen Y Transl Cancer Res. 2022; 11(8):2536-2552.
PMID: 36093512 PMC: 9459580. DOI: 10.21037/tcr-22-652.
El-Shendidi A, Ghazala R, Hassouna E Clin Exp Hepatol. 2022; 8(2):139-146.
PMID: 36092759 PMC: 9442659. DOI: 10.5114/ceh.2022.116820.
Sobolewski C, Dubuquoy L, Legrand N Cancers (Basel). 2022; 14(14).
PMID: 35884580 PMC: 9319505. DOI: 10.3390/cancers14143516.